Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LUV vs GSK✓SelectedUSD · GSKLUV vs GSK performance historyLatest closeAs of-3.10%11/19
Stock and ETF performance explorer

LUV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+5,123.6%
GSK return
+1,646.5%
Excess return
+3,477.1%
Maximum drawdown
-78.2%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.1%-1.6%-1.5%-2.6%
7D+0.8%-4.7%+5.6%+2.5%
30D+15.0%-4.7%+19.7%+17.0%
3M+10.6%-8.8%+19.4%+14.0%
6M+23.2%-4.6%+27.9%+24.7%
YTD+11.8%+1.0%+10.8%+11.0%
1Y+45.4%+6.9%+38.6%+41.6%
3Y+96.0%+52.5%+43.4%+64.4%
5Y+6.1%+40.3%-34.2%-9.6%
10Y+9.7%+99.0%-89.2%-18.0%
All+5,123.6%+1,646.5%+3,477.1%+1,825.7%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling